NTRK1 and cancer: TrkA serves as a high affinity receptor for the nerve growth factor (NGF), and therefore binding of a potential ligand results in downstream activation of Ras/MAP Kinase and PI3 Kinase pathways, which are closely associated with several cancers [5].